iSpecimen Inc. — Form 10-Q
Filed November 17, 2026 · analyzed by the Periodic Agent
10-Q
— Neutral
significance 8/100
What the filing says
Shahin Behroyan (CEO) and Yuying Liang (CFO) provided standard Sarbanes-Oxley certifications (Rules 13a-14 and Section 906) for the Q3 2026 10-Q ending September 30, 2026, filed November 17, 2026. Both officers certify the report contains no untrue statements, financial statements fairly present the company's condition and results, and disclosure controls and internal controls over financial reporting are designed and evaluated. No specific operational, financial, or control findings are detailed in these exhibit pages.
Why this rating
Routine SOX certification exhibits; no substantive business information disclosed. Standard periodic compliance filing for all public companies; immaterial to significance.
See more from November 17, 2026.
EDGAR·FLOW summarizes public SEC EDGAR filings with automated analysis. Materiality scores and stock-impact predictions are algorithmically generated and are not investment advice. Always verify against the source filing on SEC.gov.